Seegenschmiedt M H, Klautke G, Walther E, Feldmann H J, Katalinic A, Stuschke M, von Lieven H, Vaupel P
Klinik und Poliklinik für Strahlentherapie, Universität Erlangen-Nürnberg.
Strahlenther Onkol. 1996 Sep;172(9):475-84.
Water-filtered infrared-A-radiation (IR/A-HT) can be used to heat superficial malignant tumors. A prospective multicenter phase I-II study was conducted to evaluate toxicity and efficacy of IR/A-HT combined with external beam radiotherapy (RT).
PATIENTS, MATERIAL AND METHODS: From December 1991 to June 1994, a total of 53 patients with 58 malignant lesions were entered in the study. There were 14 primary, 36 recurrent and 8 metastatic tumors which were located in the head and neck region (14), chest wall (31), abdominal wall (2) and the extremities (11). The mean tumor volume was 100 cm3. IR/A-HT was applied 1 to 2 times per week with up to 3 IR/A-HT-radiators directly before or after external RT for 1 hour at 40.5 to 44 degrees C. Temperatures were controlled at various locations at the skin surface and invasively at depth.
IR/A-HT was well tolerated: in 31 (53%) lesions acute (pain, pulse or blood pressure changes, increased skin reaction etc.) and in 25 (43%) chronic side-effects (atrophy, telangiectasis, fibrosis etc.) were noted; usually the toxicity was minor and temporary. At 3 months FU, 32 (55%) lesions achieved a local CR and 19 (35%) a PR; at 12 months FU, 25 (43%) had persistent CR; 16 patients (18 lesions) were deceased and 3 (4 lesions) not yet in FU. In univariate analysis the following prognostic factors for CR at 3 or 12 months FU were found: Karnofsky, metastatic status, tumor size, total RT-dose, thermal parameters T min(av) and T mean. For acute toxicity maximum temperature Tmax(av) was prognostically decisive. Significant differences were also found when considering the "quality of the HT-application". The microwave technique was superior to the infrared-A-HT-technique with regard to the penetration depth of energy deposition.
Water-filtered infrared-A-radiation can be safely and effectively applied to heat localized superficial tumors (up to 1 cm depth). To increase the area of HT application multiple infrared-A-radiators have to be combined. A multi-element-system is in progress.
水过滤红外A辐射(IR/A-HT)可用于加热浅表恶性肿瘤。开展了一项前瞻性多中心I-II期研究,以评估IR/A-HT联合外照射放疗(RT)的毒性和疗效。
患者、材料与方法:1991年12月至1994年6月,共有53例患者的58个恶性病灶纳入本研究。其中有14个原发性肿瘤、36个复发性肿瘤和8个转移性肿瘤,位于头颈部(14个)、胸壁(31个)、腹壁(2个)和四肢(11个)。平均肿瘤体积为100 cm³。IR/A-HT每周应用1至2次,每次最多使用3个IR/A-HT辐射器,在体外放疗前后直接进行,在40.5至44摄氏度下照射1小时。在皮肤表面的不同位置以及通过侵入性方式测量深度来控制温度。
IR/A-HT耐受性良好:31个(53%)病灶出现急性(疼痛、脉搏或血压变化、皮肤反应加重等)不良反应,25个(43%)出现慢性不良反应(萎缩、毛细血管扩张、纤维化等);通常毒性较小且为暂时性。在随访3个月时,32个(55%)病灶达到局部完全缓解(CR),19个(35%)达到部分缓解(PR);在随访12个月时,25个(43%)持续保持CR;16例患者(18个病灶)死亡,3例患者(4个病灶)尚未进入随访。单因素分析发现,以下因素是随访3个月或12个月时CR的预后因素:卡氏评分、转移状态、肿瘤大小、总放疗剂量、热参数T min(av)和T mean。对于急性毒性,平均最高温度Tmax(av)具有预后决定性意义。在考虑“热疗应用质量”时也发现了显著差异。就能量沉积的穿透深度而言,微波技术优于红外A热疗技术。
水过滤红外A辐射可安全有效地用于加热局限性浅表肿瘤(深度达1 cm)。为增加热疗应用面积,必须组合多个红外A辐射器。一个多元素系统正在研发中。